Trial intelligence / Profile preview

Intranasal dexmedetomidine versus general anesthesia for dental treatment in adults with intellectual disability and dentophobia

NL-OMON28972Not yet recruiting

Sponsor
University Medical Center Groningen
Start
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of dexmedetomidine in Dentophobia (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Completion of dental treatment under intranasal dexmedetomidine procedural sedation, Completion of dental treatment under general anesthesia and 2 more. Planned start Sep 2016; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

Dentophobia

Beyond the preview

Go deeper on NL-OMON28972.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON28972.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call